Dugen Pharma Private Limited
About Dugen Pharma Private Limited
Data last updated:
Dugen Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24100PN2019PTC181928. Its GSTIN is 27AAHCD0818P1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ritu Balasaheb Kakade and Balasaheb Shivaji Kakade.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at S. No. 135 Office No. D/203 Naren Pearl Magarpatta Rdpune Hadapsar, Maharashtra, India – 411028.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.51 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹12.43 Lakh (net margin -55.2%) and EBITDA of -₹11.76 Lakh (EBITDA margin -52.2%). Revenue has grown at a compounded annual rate (CAGR) of 528% over three years and 142% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressS. No. 135 Office No. D/203 Naren Pearl Magarpatta Rdpune Hadapsar, Maharashtra, India – 411028
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dugen Pharma Private Limited
The main business activity of Dugen Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dugen Pharma Private Limited FY 2024 filings available
Dugen Pharma Private Limited reported revenue of ₹22.51 Lakh (down 74% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dugen Pharma Private Limited
Revenue fell 74% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 142%. EBITDA fell 884% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dugen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹11.76 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹12.43 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dugen Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -52.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -55.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dugen Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Dugen Pharma Private Limited
Dugen Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritu Balasaheb Kakade Also directs: RXN Chemicals Private Limited | Director | 05 Feb 2019 | 7 Years 8 Months | Current |
| Balasaheb Shivaji Kakade | Director | 05 Feb 2019 | 7 Years 8 Months | Current |
Peer Comparison of Dugen Pharma Private Limited
Dugen Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bwino Mediequip Exporters Private Limited | ₹22.93 Lakh (FY 2023) | •••• | •••• | -32.0% | •••• | Ambernath West, Maharashtra, India |
| D-Alive Health Private Limited | ₹22.92 Lakh (FY 2025) | •••• | •••• | -58.0% | •••• | Mumbai, Maharashtra, India |
| TSL Scientific Instrument Private Limited | ₹22.86 Lakh (FY 2025) | •••• | •••• | -38.0% | •••• | Delhi, India |
| Dietisure Nutraceuticals Private Limited | ₹22.81 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Delhi, India |
| Rising Curve Private Limited | ₹22.68 Lakh (FY 2025) | •••• | •••• | 2574.0% | •••• | New Delhi, Delhi, India |
| Dugen Pharma Private Limited this company | ₹22.51 Lakh (FY 2025) | •••• | •••• | -74.0% | •••• | Pune, Maharashtra, India |
| Rivaan Solution Private Limited | ₹22.5 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Dib Brothers Private Limited | ₹22.29 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Delhi, India |
| Codak Pharmaceuticals (OPC) Private Limited | ₹22.28 Lakh (FY 2025) | •••• | •••• | 87.0% | •••• | Coimbatore, Tamil Nadu, India |
| Analytica Labchem Private Limited | ₹22.25 Lakh (FY 2024) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Gabiox Global Private Limited | ₹22.07 Lakh (FY 2023) | •••• | •••• | -80.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Dugen Pharma by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dugen Pharma Private Limited
Dugen Pharma Private Limited is audited by RAKESH A SANKLECHA AND ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAKESH A SANKLECHA AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dugen Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dugen Pharma Private Limited
Dugen Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dugen Pharma Private Limited
Employment history and EPFO contributions of people linked to Dugen Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dugen Pharma Private Limited
Dugen Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Balasaheb Shivaji Kakade was appointed as Director on 05 Feb 2019.
Credit Ratings, Litigation & Regulatory Alerts for Dugen Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dugen Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dugen Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dugen Pharma Private Limited
Dugen Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCD0818P1ZB | Maharashtra | Active | 11 Oct 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dugen Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dugen Pharma Private Limited
Dugen Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 February 2019 (7+ years old) and is registered under CIN U24100PN2019PTC181928.
Dugen Pharma reported revenue of ₹22.51 Lakh for FY 2025 (down 74% YoY).
Dugen Pharma has 2 current directors:
- Ritu Balasaheb Kakade - Director
- Balasaheb Shivaji Kakade - Director
Dugen Pharma reported a net loss of ₹12.43 Lakh (net margin -55.2%) and EBITDA of -₹11.76 Lakh (EBITDA margin -52.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dugen Pharma is 528% over three years and 142% over five years. In the latest year (FY 2025) revenue fell 74%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dugen Pharma is 27AAHCD0818P1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dugen Pharma is U24100PN2019PTC181928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dugen Pharma was incorporated on 05 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Dugen Pharma by revenue are Bwino Mediequip Exporters Private Limited, D-Alive Health Private Limited, TSL Scientific Instrument Private Limited, Dietisure Nutraceuticals Private Limited, Rising Curve Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Balasaheb Shivaji Kakade was appointed as Director on 05 Feb 2019. Ritu Balasaheb Kakade was appointed as Director on 05 Feb 2019.
The registered office of Dugen Pharma is at S. No. 135 Office No. D203 Naren Pearl Magarpatta Rdpune Hadapsar, Maharashtra, India – 411028.